SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-002493
Filing Date
2013-01-08
Accepted
2013-01-08 19:00:20
Documents
2
Period of Report
2013-01-07

Document Format Files

Seq Description Document Type Size
1 KOLLINS ANNUAL OPTION GRANT rrd366395.html 4  
1 KOLLINS ANNUAL OPTION GRANT rrd366395.xml 4 3775
2 POWER OF ATTORNEY rrd328989_371818.htm EX-24. 4785
  Complete submission text file 0001181431-13-002493.txt   10057
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OXIGENE, INC. 230 THIRD AVENUE WALTHAM MA 02451
Business Address
Kollins John A (Reporting) CIK: 0001391070 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51967 | Film No.: 13519248